Brief: Clinical Evidence Supports Rapid SUBLOCADE Induction As A Strategy To Improve Retention In Opioid Use Disorder Treatment

Supernus

15/10/2025 13:13

Oct 15 (Reuters) - Indivior PLC 2IVB.D:

CLINICAL EVIDENCE SUPPORTS RAPID SUBLOCADE® INDUCTION AS A STRATEGY TO IMPROVE RETENTION IN OPIOID USE DISORDER TREATMENT

INDIVIOR PLC - RAPID INDUCTION WITH SUBLOCADE WELL TOLERATED

INDIVIOR PLC - SECOND SUBLOCADE INJECTION WELL TOLERATED AFTER ONE WEEK

Source text: ID:nPn6fkT3Ba

Further company coverage: 2IVB.D